Abbott Laboratories
Nvidia stomps the bears. Plus, Cramer's thoughts on 2 struggling portfolio names
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets rebound as Nvidia goes green: […]
Read More
Jim Cramer: It's not too late to buy this portfolio health-care stock after Friday's selloff
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. U.S. stocks jumped Monday as the Nasdaq and S & P 500 attempts to recover from back-to-back weekly losses. Major gains were seen in tech stocks to start the new […]
Read More
Here is Eli Lilly's competitive edge in GLP-1 obesity drugs and Abbott's secondary play
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Inflation relief: The stock market was […]
Read More
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters AbbVie on Tuesday said longtime executive Robert Michael will become the company’s new CEO, replacing Richard Gonzalez. Michael, who is AbbVie’s president and chief operating officer, will become the company’s second-ever CEO […]
Read More
The S&P 500 tops a report substantial that ‘clears the charts’ of resistance ahead of a week of earnings, inflation knowledge
The S & P 500 surged to a new all-time higher on Friday, confirming the stock market place is in a bull market and suggesting the rally has additional to go in 2024, in advance of a massive week of earnings and inflation info. The S & P 500 rallied more than 1% on Friday, […]
Read More
Why we like health-care stocks in 2024 despite their spotty record in presidential election years
As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical convention. The S & P 500 Health Care Sector […]
Read More
ɺ trove of rebound possibilities': Strategists change bullish on biotech and much more, choosing leading stocks
2023 was not a good year for the overall health-treatment sector, but some traders be expecting it to make a comeback this 12 months — highlighting biotech and medical tech as parts to view. “Rising from a lousy money raising atmosphere in ’22-23, exactly where early-stage biotech firms grappled to fund their Research and Advancement […]
Read More
4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured so much of the growth as Abbott Labs , […]
Read More
Walgreens and 3 other health-care stocks are going into our Bullpen watch list
We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful of company CEOs Jim interviewed at this week’s JPMorgan […]
Read More
Cramer's 7 days in advance: Earnings year kicks off following JPMorgan Health care Convention
CNBC’s Jim Cramer on Friday instructed traders what to observe for on Wall Street next 7 days, highlighting JPMorgan‘s industry-shifting health-care meeting in San Francisco. Getting location from Monday to Thursday, the meeting is a single of the year’s most significant gatherings of key industry CEOs where they expose earnings assistance and updates on clinical […]
Read More